[
  {
    "title": "科伦药业连续第二日大涨，控股子公司向默沙东授权7个在研ADC项目",
    "href": "http://stock.jrj.com.cn/2022/12/26101437237256.shtml",
    "datetime": "2022-12-26 10:14:00",
    "code": "002422"
  },
  {
    "title": "科伦药业涨停，向默沙东授权9个在研ADC项目，总金额超过100亿美元",
    "href": "http://stock.jrj.com.cn/2022/12/23132837233798.shtml",
    "datetime": "2022-12-23 13:28:34",
    "code": "002422"
  },
  {
    "title": "科伦药业涨停，控股子公司向默沙东授权7个在研ADC项目",
    "href": "http://stock.jrj.com.cn/2022/12/23093337233269.shtml",
    "datetime": "2022-12-23 09:33:45",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：子公司向默沙东授权7个在研ADC项目",
    "href": "http://stock.jrj.com.cn/2022/12/22161437231445.shtml",
    "datetime": "2022-12-22 16:14:45",
    "code": "002422"
  },
  {
    "title": "科伦药业：科伦博泰TROP2-ADC(SKB264,MK-2870)首次亮相国际乳腺癌大会",
    "href": "http://stock.jrj.com.cn/2022/12/07170537195556.shtml",
    "datetime": "2022-12-07 17:05:55",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：控股股东减持“科伦转债”约387.13万张",
    "href": "http://stock.jrj.com.cn/2022/11/25175437167483.shtml",
    "datetime": "2022-11-25 17:54:35",
    "code": "002422"
  },
  {
    "title": "科伦药业：科伦博泰公布TROP2-ADC(SKB264，MK-2870)Ⅱ期研究数据",
    "href": "http://stock.jrj.com.cn/2022/11/23004837160227.shtml",
    "datetime": "2022-11-23 00:48:05",
    "code": "002422"
  },
  {
    "title": "科伦药业：创新药物SKB264联合帕博利珠单抗获美国FDA新药临床试验批准",
    "href": "http://stock.jrj.com.cn/2022/11/15193737141454.shtml",
    "datetime": "2022-11-15 19:37:12",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：完成发行4亿元超短期融资券(科创票据)",
    "href": "http://stock.jrj.com.cn/2022/11/15165937140611.shtml",
    "datetime": "2022-11-15 16:59:29",
    "code": "002422"
  },
  {
    "title": "科伦药业子公司川宁生物发布首份社会责任报告 打造践行“两山理论”的新疆样本",
    "href": "http://stock.jrj.com.cn/2022/11/03160137109924.shtml",
    "datetime": "2022-11-03 16:01:11",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)截至10月底已累计回购0.51%股份",
    "href": "http://stock.jrj.com.cn/2022/11/01173937103763.shtml",
    "datetime": "2022-11-01 17:39:46",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)第三季度净利润5.43亿元、同比增长52.72%",
    "href": "http://stock.jrj.com.cn/2022/10/30205537097879.shtml",
    "datetime": "2022-10-30 20:55:44",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：“科伦转债”可能满足赎回条件",
    "href": "http://stock.jrj.com.cn/2022/10/21162537073420.shtml",
    "datetime": "2022-10-21 16:25:38",
    "code": "002422"
  },
  {
    "title": "科伦药业：公司泊沙康唑肠溶片获得药品注册批准",
    "href": "http://stock.jrj.com.cn/2022/10/14171137056444.shtml",
    "datetime": "2022-10-14 17:11:39",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：截至9月底已累计回购0.51%股份",
    "href": "http://stock.jrj.com.cn/2022/10/10170937044181.shtml",
    "datetime": "2022-10-10 17:09:37",
    "code": "002422"
  },
  {
    "title": "科伦药业：捐赠300万元用于支援伊宁市疫情防控工作",
    "href": "http://stock.jrj.com.cn/2022/09/30104337033226.shtml",
    "datetime": "2022-09-30 10:43:35",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：子公司再捐300万元支援伊宁市疫情防控",
    "href": "http://stock.jrj.com.cn/2022/09/30075237032756.shtml",
    "datetime": "2022-09-30 07:52:26",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：溴莫尼定噻吗洛尔滴眼液国内首仿获批",
    "href": "http://stock.jrj.com.cn/2022/09/25182637019540.shtml",
    "datetime": "2022-09-25 18:26:17",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：截至9月22日已累计回购138.28万股",
    "href": "http://stock.jrj.com.cn/2022/09/22174237014652.shtml",
    "datetime": "2022-09-22 17:42:10",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：“科伦转债”自9月26日起开始转股",
    "href": "http://stock.jrj.com.cn/2022/09/21173237011559.shtml",
    "datetime": "2022-09-21 17:32:05",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：注射用头孢曲松钠/氯化钠注射液获得药品注册批准",
    "href": "http://stock.jrj.com.cn/2022/09/19185137005736.shtml",
    "datetime": "2022-09-19 18:51:40",
    "code": "002422"
  },
  {
    "title": "科伦药业：2022年前三季归母净利润预增55%-70%",
    "href": "http://stock.jrj.com.cn/2022/09/16092536999336.shtml",
    "datetime": "2022-09-16 09:25:11",
    "code": "002422"
  },
  {
    "title": "科伦药业发布前三季度业绩预告：净利润13.51亿至14.42亿 同比增长55%-70%",
    "href": "http://stock.jrj.com.cn/2022/09/15195036998271.shtml",
    "datetime": "2022-09-15 19:50:42",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)前三季度净利润预增55%-70%",
    "href": "http://stock.jrj.com.cn/2022/09/15192336998146.shtml",
    "datetime": "2022-09-15 19:23:51",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：控股子公司已收到MSD支付的3500万美元付款",
    "href": "http://stock.jrj.com.cn/2022/09/07193736981193.shtml",
    "datetime": "2022-09-07 19:37:57",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)截至8月底已累计回购588.94万股",
    "href": "http://stock.jrj.com.cn/2022/08/31171336958568.shtml",
    "datetime": "2022-08-31 17:13:34",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)半年度净利润8.68亿元、同比增长76.15%",
    "href": "http://stock.jrj.com.cn/2022/08/30021836950062.shtml",
    "datetime": "2022-08-30 02:18:57",
    "code": "002422"
  },
  {
    "title": "科伦药业：上半年净利润8.68亿元 同比增76.15%",
    "href": "http://stock.jrj.com.cn/2022/08/29190336948473.shtml",
    "datetime": "2022-08-29 19:03:36",
    "code": "002422"
  },
  {
    "title": "川宁生物37亿债务压身6亿募资4亿还债 科伦药业募投项目“包装”上市被指圈钱",
    "href": "http://stock.jrj.com.cn/ipo/2022/08/15110236899325.shtml",
    "datetime": "2022-08-15 11:02:50",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：子公司川宁生物创业板IPO过会",
    "href": "http://stock.jrj.com.cn/2022/08/14164436897807.shtml",
    "datetime": "2022-08-14 16:44:18",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：拟7000万元受让科伦药研余下35%股权",
    "href": "http://stock.jrj.com.cn/2022/07/28180036851172.shtml",
    "datetime": "2022-07-28 18:00:28",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：科伦博泰项目B有偿许可默沙东在全球范围内商业化开发",
    "href": "http://stock.jrj.com.cn/2022/07/26154436843641.shtml",
    "datetime": "2022-07-26 15:44:37",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422)：部分回购股份注销完成暨股份变动。",
    "href": "http://stock.jrj.com.cn/2022/07/25182136840756.shtml",
    "datetime": "2022-07-25 18:21:18",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422)：可转债转股价格调整",
    "href": "http://stock.jrj.com.cn/2022/07/25181436840706.shtml",
    "datetime": "2022-07-25 18:14:16",
    "code": "002422"
  },
  {
    "title": "多瑞医药(301075.SZ)：拿下科伦药业心可舒颗粒中国独代权",
    "href": "http://stock.jrj.com.cn/2022/07/25160536840060.shtml",
    "datetime": "2022-07-25 16:05:54",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：完成发行4亿元超短期融资券",
    "href": "http://stock.jrj.com.cn/2022/07/19205136826376.shtml",
    "datetime": "2022-07-19 20:51:41",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药SKB264(TROP2-ADC)联用治疗晚期实体瘤获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/07/14162336811449.shtml",
    "datetime": "2022-07-14 16:23:09",
    "code": "002422"
  },
  {
    "title": "卷起来了！第七批药品国采开标，科伦药业11个品种上榜！“流感神药”低至0.99元/片",
    "href": "http://stock.jrj.com.cn/2022/07/13081236806099.shtml",
    "datetime": "2022-07-13 08:12:50",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：若干产品拟中标集采",
    "href": "http://stock.jrj.com.cn/2022/07/12222936805077.shtml",
    "datetime": "2022-07-12 22:29:23",
    "code": "002422"
  },
  {
    "title": "科伦药业：部分产品拟中标第七批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2022/07/12174336803893.shtml",
    "datetime": "2022-07-12 17:43:19",
    "code": "002422"
  },
  {
    "title": "科伦药业掉队研发人员锐减627人 50亿巨额市场费吞噬利润致增收不增利",
    "href": "http://stock.jrj.com.cn/2022/07/11110136798220.shtml",
    "datetime": "2022-07-11 11:01:39",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药TROP2-ADC SKB264治疗晚期三阴乳腺癌被纳入突破性治疗品种",
    "href": "http://stock.jrj.com.cn/2022/07/07120336790453.shtml",
    "datetime": "2022-07-07 12:03:08",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：截至6月底已累计回购525.78万股",
    "href": "http://stock.jrj.com.cn/2022/07/01161636775364.shtml",
    "datetime": "2022-07-01 16:16:43",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：KL340399注射液瘤内注射治疗晚期实体瘤获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/06/15195836732284.shtml",
    "datetime": "2022-06-15 19:58:47",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：钆特醇注射液获得药品注册批准",
    "href": "http://stock.jrj.com.cn/2022/05/27161436684698.shtml",
    "datetime": "2022-05-27 16:14:16",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：2021年员工持股计划完成股票购买和非交易过户",
    "href": "http://stock.jrj.com.cn/2022/05/26182136681901.shtml",
    "datetime": "2022-05-26 18:21:34",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：控股子公司获批组建生物靶向药物国家工程研究中心",
    "href": "http://stock.jrj.com.cn/2022/05/24191836675116.shtml",
    "datetime": "2022-05-24 19:18:35",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：拟继续使用部分闲置募集资金不超18亿元暂补流动资金",
    "href": "http://stock.jrj.com.cn/2022/05/16220636653067.shtml",
    "datetime": "2022-05-16 22:06:57",
    "code": "002422"
  },
  {
    "title": "科伦药业抗肿瘤新药授权MSD在中国外商业化开发 里程碑付款可达13.63亿美元",
    "href": "http://stock.jrj.com.cn/2022/05/16105736650594.shtml",
    "datetime": "2022-05-16 10:57:44",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：科伦博泰项目A有偿许可MSD公司在中国外商业化开发",
    "href": "http://stock.jrj.com.cn/2022/05/16080736649699.shtml",
    "datetime": "2022-05-16 08:07:26",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：向398名激励对象授予481.8434万股限制性股票",
    "href": "http://stock.jrj.com.cn/2022/05/09220636611573.shtml",
    "datetime": "2022-05-09 22:06:06",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：舒更葡糖钠注射液获批上市",
    "href": "http://stock.jrj.com.cn/2022/05/08182336597599.shtml",
    "datetime": "2022-05-08 18:23:00",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)2021年度分红派息10派4.26元 股权登记日为5月13日",
    "href": "http://stock.jrj.com.cn/2022/05/06193936582482.shtml",
    "datetime": "2022-05-06 19:39:27",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：截至4月底已回购181.63万股",
    "href": "http://stock.jrj.com.cn/2022/05/05202236571577.shtml",
    "datetime": "2022-05-05 20:22:59",
    "code": "002422"
  },
  {
    "title": "国内首仿！科伦药业(002422.SZ)枸橼酸西地那非口崩片获批",
    "href": "http://stock.jrj.com.cn/2022/04/29115136502734.shtml",
    "datetime": "2022-04-29 11:51:56",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：拟以1亿-2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2022/04/27003636479819.shtml",
    "datetime": "2022-04-27 00:36:20",
    "code": "002422"
  },
  {
    "title": "科伦药业：预计2022年半年度盈利6.65亿至7.64亿元 净利润同比增长35.00%至55.00%",
    "href": "http://stock.jrj.com.cn/2022/04/26215536478790.shtml",
    "datetime": "2022-04-26 21:55:24",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)一季度净利润2.91亿元 同比增长66.08%",
    "href": "http://stock.jrj.com.cn/2022/04/26181936476992.shtml",
    "datetime": "2022-04-26 18:19:56",
    "code": "002422"
  },
  {
    "title": "科伦药业：2022年第一季度净利润约2.91亿元，同比增加66%",
    "href": "http://stock.jrj.com.cn/2022/04/19145736397884.shtml",
    "datetime": "2022-04-19 14:57:02",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)业绩快报：一季度净利升66.09%至2.91亿元",
    "href": "http://stock.jrj.com.cn/2022/04/18201936387276.shtml",
    "datetime": "2022-04-18 20:19:51",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：30亿元可转债将于4月20日在深交所挂牌交易",
    "href": "http://stock.jrj.com.cn/2022/04/17180736368969.shtml",
    "datetime": "2022-04-17 18:07:26",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：“中长链脂肪乳/氨基酸(16)/葡萄糖(36％)注射液”获批上市",
    "href": "http://stock.jrj.com.cn/2022/04/13154436323559.shtml",
    "datetime": "2022-04-13 15:44:54",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)股份回购完成 累计耗资6000万元回购343.73万股",
    "href": "http://stock.jrj.com.cn/2022/04/12174936316019.shtml",
    "datetime": "2022-04-12 17:49:19",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)获3名董事、高管合计增持14.25万股",
    "href": "http://stock.jrj.com.cn/2022/04/12174436316033.shtml",
    "datetime": "2022-04-12 17:44:22",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：拟使用部分闲置募集资金不超3亿元暂补流动资金",
    "href": "http://stock.jrj.com.cn/2022/04/10183436293169.shtml",
    "datetime": "2022-04-10 18:34:25",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)2021年净利润增长32.94%至11.03亿元 拟每10股派4.26元",
    "href": "http://stock.jrj.com.cn/2022/04/10164636291866.shtml",
    "datetime": "2022-04-10 16:46:55",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药SKB264治疗晚期三阴性乳腺癌III期临床获批开展",
    "href": "http://stock.jrj.com.cn/2022/04/07154536267920.shtml",
    "datetime": "2022-04-07 15:45:09",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药SKB264联合KL-A167获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/03/31194136241609.shtml",
    "datetime": "2022-03-31 19:41:33",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药KL130008胶囊获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/03/23191634871647.shtml",
    "datetime": "2022-03-23 19:16:27",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)可转债中签号码出炉：中签号共59.3788万个",
    "href": "http://stock.jrj.com.cn/2022/03/21155634855743.shtml",
    "datetime": "2022-03-21 15:56:10",
    "code": "002422"
  },
  {
    "title": "A股异动 | 科伦药业(002422.SZ)逼近涨停 料一季度净利同比增50%-70%",
    "href": "http://stock.jrj.com.cn/2022/03/17101534837810.shtml",
    "datetime": "2022-03-17 10:15:26",
    "code": "002422"
  },
  {
    "title": "科伦药业：持续优化产品结构 一季度净利同比预增50%-70%",
    "href": "http://stock.jrj.com.cn/2022/03/16201534835902.shtml",
    "datetime": "2022-03-16 20:15:36",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)一季度净利润预增50%-70%",
    "href": "http://stock.jrj.com.cn/2022/03/16175834835007.shtml",
    "datetime": "2022-03-16 17:58:54",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：口服降糖药琥珀酸曲格列汀片获批上市",
    "href": "http://stock.jrj.com.cn/2022/03/11155034813814.shtml",
    "datetime": "2022-03-11 15:50:46",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)截至2月底已累计回购221.66万股",
    "href": "http://stock.jrj.com.cn/2022/03/01163134508247.shtml",
    "datetime": "2022-03-01 16:31:46",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药物SKB378/HBM9378注射液获批临床",
    "href": "http://stock.jrj.com.cn/2022/02/21170534422854.shtml",
    "datetime": "2022-02-21 17:05:12",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)获批发行不超30亿元可转债",
    "href": "http://stock.jrj.com.cn/2022/02/10181034318976.shtml",
    "datetime": "2022-02-10 18:10:02",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：利格列汀片获得药品注册批准",
    "href": "http://stock.jrj.com.cn/2022/02/09154534313332.shtml",
    "datetime": "2022-02-09 15:45:23",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)截至1月底已累计回购221.66万股",
    "href": "http://stock.jrj.com.cn/2022/02/07203334303065.shtml",
    "datetime": "2022-02-07 20:33:48",
    "code": "002422"
  },
  {
    "title": "科伦药业：公开发行可转换公司债申请获证监会审核通过",
    "href": "http://stock.jrj.com.cn/2022/01/18130134169218.shtml",
    "datetime": "2022-01-18 13:01:48",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：可转债发行申请获证监会审核通过",
    "href": "http://stock.jrj.com.cn/2022/01/18114834168894.shtml",
    "datetime": "2022-01-18 11:48:55",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药物KL340399注射液(STING激动剂)获批临床",
    "href": "http://stock.jrj.com.cn/2022/01/11155834146107.shtml",
    "datetime": "2022-01-11 15:58:39",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)业绩快报：2021年扣非净利润升61.54%至10.15亿元",
    "href": "http://stock.jrj.com.cn/2022/01/07184034134423.shtml",
    "datetime": "2022-01-07 18:40:15",
    "code": "002422"
  },
  {
    "title": "科伦药业：已回购221.66万股 成交金额约4000.51万元",
    "href": "http://stock.jrj.com.cn/2022/01/05100434124956.shtml",
    "datetime": "2022-01-05 10:04:22",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：截至11月30日已累计回购221.66万股",
    "href": "http://stock.jrj.com.cn/2021/11/30201933945735.shtml",
    "datetime": "2021-11-30 20:19:51",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)拟推500.26万股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/11/30115633942993.shtml",
    "datetime": "2021-11-30 11:56:09",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：成功发行8亿元超短期融资券",
    "href": "http://stock.jrj.com.cn/2021/11/25214233920530.shtml",
    "datetime": "2021-11-25 21:42:42",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：拟推出员工持股计划",
    "href": "http://stock.jrj.com.cn/2021/11/22174733904612.shtml",
    "datetime": "2021-11-22 17:47:40",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：拟筹划推出股权激励计划事项",
    "href": "http://stock.jrj.com.cn/2021/11/22174533904546.shtml",
    "datetime": "2021-11-22 17:45:49",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：PD-L1新药泰特利单抗注射液上市申请获NMPA受理",
    "href": "http://stock.jrj.com.cn/2021/11/19160633880119.shtml",
    "datetime": "2021-11-19 16:06:11",
    "code": "002422"
  },
  {
    "title": "科伦药业：PD-L1新药泰特利单抗注射液上市申请获受理",
    "href": "http://stock.jrj.com.cn/2021/11/19160333880110.shtml",
    "datetime": "2021-11-19 16:03:22",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：注射用SKB315用于开展晚期实体瘤的临床试验获批",
    "href": "http://stock.jrj.com.cn/2021/11/04173633813300.shtml",
    "datetime": "2021-11-04 17:36:38",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：截至10月底已累计回购221.66万股",
    "href": "http://stock.jrj.com.cn/2021/11/03172533808982.shtml",
    "datetime": "2021-11-03 17:25:23",
    "code": "002422"
  },
  {
    "title": "科伦药业：前三季度净利润8.48亿元，同比增长69.16%",
    "href": "http://stock.jrj.com.cn/2021/10/31144133784608.shtml",
    "datetime": "2021-10-31 14:41:26",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)前三季度扣非净利润劲升110.56%至8.03亿元",
    "href": "http://stock.jrj.com.cn/2021/10/29170933778059.shtml",
    "datetime": "2021-10-29 17:09:58",
    "code": "002422"
  },
  {
    "title": "科伦药业：子公司钆塞酸二钠注射液获得药品注册批准",
    "href": "http://stock.jrj.com.cn/2021/09/28141033530028.shtml",
    "datetime": "2021-09-28 14:10:14",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：子公司钆塞酸二钠注射液获批上市",
    "href": "http://stock.jrj.com.cn/2021/09/28115433529356.shtml",
    "datetime": "2021-09-28 11:54:13",
    "code": "002422"
  },
  {
    "title": "国内首家！ 科伦药业(002422.SZ)注射用头孢他啶/5%葡萄糖注射液获批上市",
    "href": "http://stock.jrj.com.cn/2021/09/28115133529347.shtml",
    "datetime": "2021-09-28 11:51:03",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：将在ESMO年会上口头报告自主创新药物TROP2-ADC SKB264中美I期临床研究结果",
    "href": "http://stock.jrj.com.cn/2021/09/17161333451769.shtml",
    "datetime": "2021-09-17 16:13:24",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：就协议受让辰欣药业股份已完成过户",
    "href": "http://stock.jrj.com.cn/2021/09/15160633439818.shtml",
    "datetime": "2021-09-15 16:06:37",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：已累计耗资4000.51万元回购221.66万股",
    "href": "http://stock.jrj.com.cn/2021/08/31181133362626.shtml",
    "datetime": "2021-08-31 18:11:33",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：新一轮回购计划首次回购1002.40万元股份",
    "href": "http://stock.jrj.com.cn/2021/08/30171233352948.shtml",
    "datetime": "2021-08-30 17:12:41",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)上半年净利大增142.96%至4.93亿元",
    "href": "http://stock.jrj.com.cn/2021/08/25190033318062.shtml",
    "datetime": "2021-08-25 19:00:42",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：子公司川宁生物创业板IPO申请获深交所受理",
    "href": "http://stock.jrj.com.cn/2021/08/23213233305236.shtml",
    "datetime": "2021-08-23 21:32:50",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：持股5%以上的雅安国资公司已增持55.96万股",
    "href": "http://stock.jrj.com.cn/2021/08/05174933208069.shtml",
    "datetime": "2021-08-05 17:49:57",
    "code": "002422"
  },
  {
    "title": "科伦药业：持股5%以上股东所持1276万股解除质押",
    "href": "http://stock.jrj.com.cn/2021/08/04171133202275.shtml",
    "datetime": "2021-08-04 17:11:13",
    "code": "002422"
  },
  {
    "title": "科伦药业及石四药受让辰欣药业16%股份 三大上市药企深度绑定提升行业集中度",
    "href": "http://stock.jrj.com.cn/2021/08/03074433193298.shtml",
    "datetime": "2021-08-03 07:44:37",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：发行可转债申请获证监会受理",
    "href": "http://stock.jrj.com.cn/2021/08/02211633190800.shtml",
    "datetime": "2021-08-02 21:16:46",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：拟协议受让辰欣药业10%的股份",
    "href": "http://stock.jrj.com.cn/2021/07/29173533170216.shtml",
    "datetime": "2021-07-29 17:35:56",
    "code": "002422"
  },
  {
    "title": "科伦药业将花不超6000万回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/07/26171233152801.shtml",
    "datetime": "2021-07-26 17:12:07",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：完成回购 累计耗资5999.31万元回购319.4万股",
    "href": "http://stock.jrj.com.cn/2021/07/23193933141577.shtml",
    "datetime": "2021-07-23 19:39:01",
    "code": "002422"
  },
  {
    "title": "科伦药业将花不超6000万元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/07/21212733131622.shtml",
    "datetime": "2021-07-21 21:27:54",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：拟以4000万-6000万元回购公司股份",
    "href": "http://stock.jrj.com.cn/2021/07/21202333131305.shtml",
    "datetime": "2021-07-21 20:23:20",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：控股股东提议公司以4000万-6000万元回购股份",
    "href": "http://stock.jrj.com.cn/2021/07/19200233120550.shtml",
    "datetime": "2021-07-19 20:02:25",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：总经理刘思川7月15日增持10万股",
    "href": "http://stock.jrj.com.cn/2021/07/15165533102176.shtml",
    "datetime": "2021-07-15 16:55:32",
    "code": "002422"
  },
  {
    "title": "科伦药业发行4亿短期融资券 票面利率3.5%",
    "href": "http://stock.jrj.com.cn/2021/07/13220533091230.shtml",
    "datetime": "2021-07-13 22:05:31",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：总经理刘思川7月13日增持10万股",
    "href": "http://stock.jrj.com.cn/2021/07/13172533089870.shtml",
    "datetime": "2021-07-13 17:25:11",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：总经理刘思川7月8日增持5万股",
    "href": "http://stock.jrj.com.cn/2021/07/08163933064550.shtml",
    "datetime": "2021-07-08 16:39:12",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)2020年度分红派息10派3.188元 股权登记日为7月14日",
    "href": "http://stock.jrj.com.cn/2021/07/07184133059653.shtml",
    "datetime": "2021-07-07 18:41:11",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：7月2日包括总经理在内的部分高管合计购买28.39万股",
    "href": "http://stock.jrj.com.cn/2021/07/02183133034623.shtml",
    "datetime": "2021-07-02 18:31:21",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药物SKB336注射液获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/07/02164533033950.shtml",
    "datetime": "2021-07-02 16:45:43",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：KL280006注射液获批开展尿毒症瘙痒的临床试验",
    "href": "http://stock.jrj.com.cn/2021/06/24193432991125.shtml",
    "datetime": "2021-06-24 19:34:01",
    "code": "002422"
  },
  {
    "title": "科伦药业：公司已建设生物药的生产体系",
    "href": "http://stock.jrj.com.cn/2021/06/23213232985250.shtml",
    "datetime": "2021-06-23 21:32:24",
    "code": "002422"
  },
  {
    "title": "科伦药业：公司研究院临床研究体系正在快速成长和进步过程中",
    "href": "http://stock.jrj.com.cn/2021/06/23213232985248.shtml",
    "datetime": "2021-06-23 21:32:18",
    "code": "002422"
  },
  {
    "title": "科伦药业：科伦博泰目前聚焦在ADC领域集中开发",
    "href": "http://stock.jrj.com.cn/2021/06/23213132985241.shtml",
    "datetime": "2021-06-23 21:31:32",
    "code": "002422"
  },
  {
    "title": "科伦药业：A167淋巴瘤适应症已提交pre-NDA",
    "href": "http://stock.jrj.com.cn/2021/06/23212732985201.shtml",
    "datetime": "2021-06-23 21:27:46",
    "code": "002422"
  },
  {
    "title": "科伦药业：A264首发适应症拓展研究正在全力入组",
    "href": "http://stock.jrj.com.cn/2021/06/23212732985199.shtml",
    "datetime": "2021-06-23 21:27:34",
    "code": "002422"
  },
  {
    "title": "科伦药业：不存在被动减持的风险",
    "href": "http://stock.jrj.com.cn/2021/06/22100432974762.shtml",
    "datetime": "2021-06-22 10:04:19",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：碘帕醇注射液为科伦首个获批进入诊断造影领域的药物",
    "href": "http://stock.jrj.com.cn/2021/06/21162032969736.shtml",
    "datetime": "2021-06-21 16:20:45",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：盐酸厄洛替尼片获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/21161832969729.shtml",
    "datetime": "2021-06-21 16:18:24",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：氨基酸(15)腹膜透析液获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/21114932968505.shtml",
    "datetime": "2021-06-21 11:49:08",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：将快速推动A166开展治疗HER2阳性乳腺癌关键II期临床试验",
    "href": "http://stock.jrj.com.cn/2021/06/20172532961212.shtml",
    "datetime": "2021-06-20 17:25:29",
    "code": "002422"
  },
  {
    "title": "科伦药业：公司控股股东部分股份质押及解除质押",
    "href": "http://stock.jrj.com.cn/2021/06/18171432955506.shtml",
    "datetime": "2021-06-18 17:14:21",
    "code": "002422"
  },
  {
    "title": "科伦药业拟分拆子公司川宁生物至创业板IPO，仍保持对其控制权",
    "href": "http://stock.jrj.com.cn/2021/06/18101532952928.shtml",
    "datetime": "2021-06-18 10:15:54",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：拟分拆川宁生物至深交所创业板上市",
    "href": "http://stock.jrj.com.cn/2021/06/17202932949421.shtml",
    "datetime": "2021-06-17 20:29:19",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)拟发行不超30亿元可转债 用于创新制剂生产线及配套建设项目等",
    "href": "http://stock.jrj.com.cn/2021/06/17202532949408.shtml",
    "datetime": "2021-06-17 20:25:56",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：用于RET融合或突变的晚期实体瘤治疗的创新药物KL590586胶囊获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/06/08202832895429.shtml",
    "datetime": "2021-06-08 20:28:47",
    "code": "002422"
  },
  {
    "title": "科伦药业：部分回购股份注销完成暨股份变动",
    "href": "http://stock.jrj.com.cn/2021/05/26172032824115.shtml",
    "datetime": "2021-05-26 17:20:21",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422)：公司控股股东部分股份质押及解除质押",
    "href": "http://stock.jrj.com.cn/2021/05/21170232794179.shtml",
    "datetime": "2021-05-21 17:02:58",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)披露创新药物A166于ASCO官网上公布研究结果摘要",
    "href": "http://stock.jrj.com.cn/2021/05/21144932793182.shtml",
    "datetime": "2021-05-21 14:49:23",
    "code": "002422"
  },
  {
    "title": "科伦药业：湖南科伦注射用奥美拉唑钠通过仿制药一致性评价 将进一步提升产品市场竞争力",
    "href": "http://stock.jrj.com.cn/2021/05/21140532793178.shtml",
    "datetime": "2021-05-21 14:05:34",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：注射用奥美拉唑钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/21120932792599.shtml",
    "datetime": "2021-05-21 12:09:02",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：马来酸阿法替尼片获批上市",
    "href": "http://stock.jrj.com.cn/2021/05/14160132755367.shtml",
    "datetime": "2021-05-14 16:01:41",
    "code": "002422"
  },
  {
    "title": "科伦药业：公司分拆川宁生物独立上市 将进一步完善川宁生物现代公司治理结构",
    "href": "http://stock.jrj.com.cn/2021/05/10154932729762.shtml",
    "datetime": "2021-05-10 15:49:23",
    "code": "002422"
  },
  {
    "title": "科伦药业：研究院临床研究体系建设是在2017年仅能开展简单BE研究的单薄基础上起步的",
    "href": "http://stock.jrj.com.cn/2021/05/10154232729715.shtml",
    "datetime": "2021-05-10 15:42:47",
    "code": "002422"
  },
  {
    "title": "科伦药业：目前整个项目组正在全力推进川宁分拆上市项目进程",
    "href": "http://stock.jrj.com.cn/2021/05/10154232729710.shtml",
    "datetime": "2021-05-10 15:42:31",
    "code": "002422"
  },
  {
    "title": "科伦药业：目前公司已有十余个创新药物进入临床阶段",
    "href": "http://stock.jrj.com.cn/2021/05/10154132729711.shtml",
    "datetime": "2021-05-10 15:41:53",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：中长链脂肪乳/氨基酸(16)/葡萄糖(16%)注射液国内首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/29175432480865.shtml",
    "datetime": "2021-04-29 17:54:26",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：注射用头孢他啶通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/29175132480849.shtml",
    "datetime": "2021-04-29 17:51:41",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)披露年报：营收165亿元及研发投入达15亿元 拟10派3.188元",
    "href": "http://stock.jrj.com.cn/2021/04/27212832465589.shtml",
    "datetime": "2021-04-27 21:28:21",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)一季度净利润升701.49%至1.75亿元",
    "href": "http://stock.jrj.com.cn/2021/04/27212032465556.shtml",
    "datetime": "2021-04-27 21:20:34",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药KL210122片获临床试验通知书",
    "href": "http://stock.jrj.com.cn/2021/04/23175332431003.shtml",
    "datetime": "2021-04-23 17:53:04",
    "code": "002422"
  },
  {
    "title": "科伦药业2021年第一季度预计净利增长631%-814% 价格恢复性上涨",
    "href": "http://stock.jrj.com.cn/2021/04/18133432393034.shtml",
    "datetime": "2021-04-18 13:34:36",
    "code": "002422"
  },
  {
    "title": "兴华基金2021一季报出炉，2只基金第一重仓股均为科伦药业",
    "href": "http://stock.jrj.com.cn/2021/04/16154832386630.shtml",
    "datetime": "2021-04-16 15:48:09",
    "code": "002422"
  },
  {
    "title": "科伦药业2020年度净利下滑11.57% 非输液制剂产品销量下降",
    "href": "http://stock.jrj.com.cn/2021/04/15190532381070.shtml",
    "datetime": "2021-04-15 19:05:29",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：盐酸莫西沙星滴眼液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/04/15162732379912.shtml",
    "datetime": "2021-04-15 16:27:56",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)一季度净利润预增630.95%-813.69%",
    "href": "http://stock.jrj.com.cn/2021/04/14200032373385.shtml",
    "datetime": "2021-04-14 20:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：罗红霉素片国内首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/14184332372971.shtml",
    "datetime": "2021-04-14 18:43:56",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：富马酸丙酚替诺福韦片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/04/12180532358638.shtml",
    "datetime": "2021-04-12 18:05:32",
    "code": "002422"
  },
  {
    "title": "A股异动 | 科伦药业(002422.SZ)涨超4% 子公司与Ellipses达成区域授权合作协议",
    "href": "http://stock.jrj.com.cn/2021/03/26145432222562.shtml",
    "datetime": "2021-03-26 14:54:32",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：授权Ellipses在除大中华区及部分亚太地区外开发、销售RET激酶抑制剂",
    "href": "http://stock.jrj.com.cn/2021/03/25165132216391.shtml",
    "datetime": "2021-03-25 16:51:57",
    "code": "002422"
  },
  {
    "title": "科伦药业：苹果酸舒尼替尼胶囊获药品注册证书 将进一步丰富公司肿瘤领域产品管线",
    "href": "http://stock.jrj.com.cn/2021/03/24134832208256.shtml",
    "datetime": "2021-03-24 13:48:39",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：苹果酸舒尼替尼胶囊获批",
    "href": "http://stock.jrj.com.cn/2021/03/24115432207519.shtml",
    "datetime": "2021-03-24 11:54:00",
    "code": "002422"
  },
  {
    "title": "科伦药业发行5亿短期融资券 票面利率4.49%",
    "href": "http://stock.jrj.com.cn/2021/03/19192532165616.shtml",
    "datetime": "2021-03-19 19:25:10",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)完成发行2021年度第二期超短期融资券(高成长债)",
    "href": "http://stock.jrj.com.cn/2021/03/19162532164362.shtml",
    "datetime": "2021-03-19 16:25:33",
    "code": "002422"
  },
  {
    "title": "科伦药业涨停 近期获多家机构调研",
    "href": "http://stock.jrj.com.cn/2021/03/17190032152471.shtml",
    "datetime": "2021-03-17 19:00:05",
    "code": "002422"
  },
  {
    "title": "【龙虎榜】科伦药业3月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/17180232152148.shtml",
    "datetime": "2021-03-17 18:02:34",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)放量涨停",
    "href": "http://stock.jrj.com.cn/2021/03/17112632150182.shtml",
    "datetime": "2021-03-17 11:26:17",
    "code": "002422"
  },
  {
    "title": "科伦药业：公司前期的重大的投资已形成生产力 如川宁项目已持续盈利",
    "href": "http://stock.jrj.com.cn/2021/03/10130732103074.shtml",
    "datetime": "2021-03-10 13:07:25",
    "code": "002422"
  },
  {
    "title": "科伦药业：科伦已经于2021年2月递交了6.0mg关键二期的CDE咨询，预计在5月会有回复",
    "href": "http://stock.jrj.com.cn/2021/03/10130632103073.shtml",
    "datetime": "2021-03-10 13:06:00",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：盐酸替罗非班氯化钠注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/03175732064545.shtml",
    "datetime": "2021-03-03 17:57:00",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：脂肪乳注射液(C14~24)国内首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/01120832049159.shtml",
    "datetime": "2021-03-01 12:08:20",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：甲硝唑氯化钠注射液国内首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/01120532049153.shtml",
    "datetime": "2021-03-01 12:05:49",
    "code": "002422"
  },
  {
    "title": "科伦药业高负债下扩张不止 分拆川宁生物谋上市",
    "href": "http://stock.jrj.com.cn/2021/02/26072632030416.shtml",
    "datetime": "2021-02-26 07:26:03",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：创新药物SKB337注射液获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/02/08192831871735.shtml",
    "datetime": "2021-02-08 19:28:07",
    "code": "002422"
  },
  {
    "title": "科伦药业：氟康唑氯化钠注射液等通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/31162431816789.shtml",
    "datetime": "2021-01-31 16:24:19",
    "code": "002422"
  },
  {
    "title": "科伦药业：两款肠外营养产品获批上市 收涨逾3%",
    "href": "http://stock.jrj.com.cn/2021/01/29160531809542.shtml",
    "datetime": "2021-01-29 16:05:31",
    "code": "002422"
  },
  {
    "title": "科伦药业：公司旗下两款产品分别获得《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2021/01/29144231808978.shtml",
    "datetime": "2021-01-29 14:42:19",
    "code": "002422"
  },
  {
    "title": "午间公告：科伦药业新药获批上市",
    "href": "http://stock.jrj.com.cn/2021/01/29122631808232.shtml",
    "datetime": "2021-01-29 12:26:06",
    "code": "002422"
  },
  {
    "title": "[科伦药业]四川省委省政府政策决策咨询委员会领导一行莅临科伦药物研究院调研指导",
    "href": "http://stock.jrj.com.cn/2021/01/27000031790958.shtml",
    "datetime": "2021-01-27 00:00:00",
    "code": "002422"
  },
  {
    "title": "[科伦药业]杭州市对口支援和区域合作局党组书记、局长杨钊率团到浙江国镜调研",
    "href": "http://stock.jrj.com.cn/2021/01/26000031778159.shtml",
    "datetime": "2021-01-26 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业发行4亿超短期融资券 票面利率3.7%",
    "href": "http://stock.jrj.com.cn/2021/01/25214431769048.shtml",
    "datetime": "2021-01-25 21:44:44",
    "code": "002422"
  },
  {
    "title": "[科伦药业]山东科伦获评山东省第六批省级工业设计中心",
    "href": "http://stock.jrj.com.cn/2021/01/21000031737636.shtml",
    "datetime": "2021-01-21 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业将花不超1亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/01/20195031731039.shtml",
    "datetime": "2021-01-20 19:50:09",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)拟以5000万-10000万元回购公司股份",
    "href": "http://stock.jrj.com.cn/2021/01/20172731729985.shtml",
    "datetime": "2021-01-20 17:27:52",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：盐酸右美托咪定注射液通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/20115431727749.shtml",
    "datetime": "2021-01-20 11:54:01",
    "code": "002422"
  },
  {
    "title": "[科伦药业]国家环境保护抗生素菌渣无害化处理与资源化利用工程技术中心通过生态环境部验收",
    "href": "http://stock.jrj.com.cn/2021/01/20000031726196.shtml",
    "datetime": "2021-01-20 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：子公司川宁生物建设的工程技术中心通过验收",
    "href": "http://stock.jrj.com.cn/2021/01/19202031723783.shtml",
    "datetime": "2021-01-19 20:20:24",
    "code": "002422"
  },
  {
    "title": "科伦药业总经理刘思川拟增持公司股份 增持金额不超过1200万元",
    "href": "http://stock.jrj.com.cn/2021/01/18212731717257.shtml",
    "datetime": "2021-01-18 21:27:55",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：总经理刘思川拟以600万-1200万元增持公司股份",
    "href": "http://stock.jrj.com.cn/2021/01/18191131716646.shtml",
    "datetime": "2021-01-18 19:11:10",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：控股股东提议以0.5亿元-1亿元回购股份",
    "href": "http://stock.jrj.com.cn/2021/01/18190931716629.shtml",
    "datetime": "2021-01-18 19:09:21",
    "code": "002422"
  },
  {
    "title": "科伦药业：中/长链脂肪乳注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/18142931714980.shtml",
    "datetime": "2021-01-18 14:29:21",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：中/长链脂肪乳注射液(C8~24Ve)通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/18114931714082.shtml",
    "datetime": "2021-01-18 11:49:37",
    "code": "002422"
  },
  {
    "title": "科伦药业股东雅安国资公司质押834万股 用于项目建设",
    "href": "http://stock.jrj.com.cn/2021/01/15195031701015.shtml",
    "datetime": "2021-01-15 19:50:00",
    "code": "002422"
  },
  {
    "title": "[科伦药业]变革营销体系,解放生产力——科伦营销中心正式成立",
    "href": "http://stock.jrj.com.cn/2021/01/15000031699009.shtml",
    "datetime": "2021-01-15 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)获董事、副总经理王晶翼增持10万股",
    "href": "http://stock.jrj.com.cn/2021/01/11170831670880.shtml",
    "datetime": "2021-01-11 17:08:39",
    "code": "002422"
  },
  {
    "title": "科伦药业净利润预减 负债率继续上升 重整业绩难",
    "href": "http://stock.jrj.com.cn/2021/01/08080431686829.shtml",
    "datetime": "2021-01-08 08:04:00",
    "code": "002422"
  },
  {
    "title": "科伦药业净利润预减 负债率继续上升 重整业绩难",
    "href": "http://stock.jrj.com.cn/2021/01/08080431652997.shtml",
    "datetime": "2021-01-08 08:04:00",
    "code": "002422"
  },
  {
    "title": "科伦药业净利润预减 负债率继续上升 重整业绩难",
    "href": "http://stock.jrj.com.cn/2021/01/08080431690492.shtml",
    "datetime": "2021-01-08 08:04:00",
    "code": "002422"
  },
  {
    "title": "科伦药业2020年预计净利8亿-8.8亿 研发投入增加",
    "href": "http://stock.jrj.com.cn/2021/01/07215231650232.shtml",
    "datetime": "2021-01-07 21:52:35",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)2020年度预盈8亿-8.8亿元 仿制药持续放量",
    "href": "http://stock.jrj.com.cn/2021/01/07184331649442.shtml",
    "datetime": "2021-01-07 18:43:03",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：获得“注射用头孢曲松钠”的药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2020/12/29212731597579.shtml",
    "datetime": "2020-12-29 21:27:01",
    "code": "002422"
  },
  {
    "title": "[科伦药业]科伦药业荣获首届四川省天府质量奖提名奖",
    "href": "http://stock.jrj.com.cn/2020/12/29000031596773.shtml",
    "datetime": "2020-12-29 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：高管万阳浴已购买1万股",
    "href": "http://stock.jrj.com.cn/2020/12/28184831587769.shtml",
    "datetime": "2020-12-28 18:48:38",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：左氧氟沙星氯化钠注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/12/28184731587764.shtml",
    "datetime": "2020-12-28 18:47:00",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：高管葛均友购买公司股票2万股",
    "href": "http://stock.jrj.com.cn/2020/12/25191231571813.shtml",
    "datetime": "2020-12-25 19:12:55",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：两名高管23日合计买入5.1万股",
    "href": "http://stock.jrj.com.cn/2020/12/23200631555658.shtml",
    "datetime": "2020-12-23 20:06:09",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：出资1200万元投设科技型物流控股子公司",
    "href": "http://stock.jrj.com.cn/2020/12/22174831546241.shtml",
    "datetime": "2020-12-22 17:48:18",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：三名监事、高管22日合计买入15万股",
    "href": "http://stock.jrj.com.cn/2020/12/22172031546086.shtml",
    "datetime": "2020-12-22 17:20:41",
    "code": "002422"
  },
  {
    "title": "新品密集获批 科伦药业创新药未来可期",
    "href": "http://stock.jrj.com.cn/2020/12/18002931512689.shtml",
    "datetime": "2020-12-18 00:29:49",
    "code": "002422"
  },
  {
    "title": "[科伦药业]中国工程院院士、温州医科大学校长李校堃到浙江国镜调研",
    "href": "http://stock.jrj.com.cn/2020/12/16000031503931.shtml",
    "datetime": "2020-12-16 00:00:00",
    "code": "002422"
  },
  {
    "title": "[科伦药业]温州医科大学科伦医学学科发展研究院与创新药物联合研发中心正式揭牌",
    "href": "http://stock.jrj.com.cn/2020/12/16000031503930.shtml",
    "datetime": "2020-12-16 00:00:00",
    "code": "002422"
  },
  {
    "title": "[科伦药业]贵州科伦空调大组长石磊获评“贵州省劳动模范”",
    "href": "http://stock.jrj.com.cn/2020/12/15000031495929.shtml",
    "datetime": "2020-12-15 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业股东雅安国资公司质押1276万股 用于项目建设",
    "href": "http://stock.jrj.com.cn/2020/12/11193831466724.shtml",
    "datetime": "2020-12-11 19:38:39",
    "code": "002422"
  },
  {
    "title": "[科伦药业]浙江省副省长陈奕君到浙江国镜调研",
    "href": "http://stock.jrj.com.cn/2020/12/09000031449493.shtml",
    "datetime": "2020-12-09 00:00:00",
    "code": "002422"
  },
  {
    "title": "[科伦药业]新都基地总经理刘文军、安岳分公司总工程师陈彪获评“四川省劳动模范”",
    "href": "http://stock.jrj.com.cn/2020/12/02000031397131.shtml",
    "datetime": "2020-12-02 00:00:00",
    "code": "002422"
  },
  {
    "title": "[科伦药业]迎难而上 热衷于和问题“较真” 广东科伦技术员黄国玉获评全国劳动模范",
    "href": "http://stock.jrj.com.cn/2020/11/25000031345187.shtml",
    "datetime": "2020-11-25 00:00:00",
    "code": "002422"
  },
  {
    "title": "[科伦药业]科伦药业环境信息披露质量连续两年获评第二名",
    "href": "http://stock.jrj.com.cn/2020/11/23000031345189.shtml",
    "datetime": "2020-11-23 00:00:00",
    "code": "002422"
  },
  {
    "title": "[科伦药业]绵阳科伦医贸总经理马晓晖获评四川省抗击新冠肺炎疫情先进个人",
    "href": "http://stock.jrj.com.cn/2020/11/20000031324186.shtml",
    "datetime": "2020-11-20 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：4个品种均已完成初步研究 已有批量试生产样品",
    "href": "http://stock.jrj.com.cn/2020/11/13144831275269.shtml",
    "datetime": "2020-11-13 14:48:28",
    "code": "002422"
  },
  {
    "title": "[科伦药业]湖北省副省长肖菊华一行到湖北科伦走访调研",
    "href": "http://stock.jrj.com.cn/2020/11/13000031305094.shtml",
    "datetime": "2020-11-13 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：丙泊酚中/长链脂肪乳注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/11/11120231258639.shtml",
    "datetime": "2020-11-11 12:02:39",
    "code": "002422"
  },
  {
    "title": "科伦药业(002422.SZ)：脂肪乳氨基酸(17)葡萄糖(11%)注射液国内首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/11/11115931258640.shtml",
    "datetime": "2020-11-11 11:59:43",
    "code": "002422"
  },
  {
    "title": "科伦药业控股股东刘革新合计质押2529万股 用于个人资金需求",
    "href": "http://stock.jrj.com.cn/2020/11/06200431232279.shtml",
    "datetime": "2020-11-06 20:04:50",
    "code": "002422"
  },
  {
    "title": "科伦药业2020年前三季度净利5.01亿下滑45.15% 营业外支出同比增长",
    "href": "http://stock.jrj.com.cn/2020/11/01161331184041.shtml",
    "datetime": "2020-11-01 16:13:16",
    "code": "002422"
  },
  {
    "title": "科伦药业短期融资券发行 总额为8亿元",
    "href": "http://stock.jrj.com.cn/2020/10/19215531086148.shtml",
    "datetime": "2020-10-19 21:55:47",
    "code": "002422"
  },
  {
    "title": "[科伦药业]十三届全国人大代表第三小组代表到浙江国镜调研",
    "href": "http://stock.jrj.com.cn/2020/09/30000030866492.shtml",
    "datetime": "2020-09-30 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业控股股东再质押1565万股 创新难突破 还面临行业“大洗牌”",
    "href": "http://stock.jrj.com.cn/2020/09/27092830842707.shtml",
    "datetime": "2020-09-27 09:28:00",
    "code": "002422"
  },
  {
    "title": "科伦药业控股股东刘革新质押1565万股 用于个人资金需求",
    "href": "http://stock.jrj.com.cn/2020/09/24202530827139.shtml",
    "datetime": "2020-09-24 20:25:47",
    "code": "002422"
  },
  {
    "title": "[科伦药业]开启合作新征程 书写合作新篇章 科伦药业携手龙泉市委市政府与温州医科大学达成战略合作",
    "href": "http://stock.jrj.com.cn/2020/09/17000030768752.shtml",
    "datetime": "2020-09-17 00:00:00",
    "code": "002422"
  },
  {
    "title": "坚持创新驱动，科伦药业加快研发沉淀",
    "href": "http://stock.jrj.com.cn/2020/09/04071630673078.shtml",
    "datetime": "2020-09-04 07:16:00",
    "code": "002422"
  },
  {
    "title": "科伦药业2020年上半年净利2.03亿减少72% 非输液产品销量下降",
    "href": "http://stock.jrj.com.cn/2020/08/31185430644890.shtml",
    "datetime": "2020-08-31 18:54:18",
    "code": "002422"
  },
  {
    "title": "科伦药业：产品线不断丰富 组织架构调整及股权激励促进提质增效",
    "href": "http://stock.jrj.com.cn/2020/08/31175430644433.shtml",
    "datetime": "2020-08-31 17:54:26",
    "code": "002422"
  },
  {
    "title": "[科伦药业]科伦药业荣登2019年度中国医药工业百强榜单",
    "href": "http://stock.jrj.com.cn/2020/08/31000030642764.shtml",
    "datetime": "2020-08-31 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/08/30233030624465.shtml",
    "datetime": "2020-08-30 23:30:01",
    "code": "002422"
  },
  {
    "title": "科伦药业多个药品拟中标第三批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/08/21192830559130.shtml",
    "datetime": "2020-08-21 19:28:14",
    "code": "002422"
  },
  {
    "title": "科伦药业恩格列净片获药品注册证书 公司首入糖尿病领域",
    "href": "http://stock.jrj.com.cn/2020/08/14211430501437.shtml",
    "datetime": "2020-08-14 21:14:40",
    "code": "002422"
  },
  {
    "title": "[科伦药业]科伦荣膺2019年中国医药工业百强前三甲",
    "href": "http://stock.jrj.com.cn/2020/08/07000030460235.shtml",
    "datetime": "2020-08-07 00:00:00",
    "code": "002422"
  },
  {
    "title": "午间公告：科伦药业子公司创新肿瘤免疫药物获临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/08/04122130422424.shtml",
    "datetime": "2020-08-04 12:21:46",
    "code": "002422"
  },
  {
    "title": "科伦药业股东刘革新质押2200万股 用于个人资金需求",
    "href": "http://stock.jrj.com.cn/2020/07/24205730335750.shtml",
    "datetime": "2020-07-24 20:57:02",
    "code": "002422"
  },
  {
    "title": "科伦药业：盐酸伐地那非片及奥氮平片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/07/24204730335720.shtml",
    "datetime": "2020-07-24 20:47:21",
    "code": "002422"
  },
  {
    "title": "[科伦药业]湖南省副省长何报翔率队到湖南科伦调研",
    "href": "http://stock.jrj.com.cn/2020/07/07000030168428.shtml",
    "datetime": "2020-07-07 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：拟分拆所属子公司川宁生物至创业板上市",
    "href": "http://stock.jrj.com.cn/2020/06/24214430012606.shtml",
    "datetime": "2020-06-24 21:44:10",
    "code": "002422"
  },
  {
    "title": "科伦药业：拟分拆所属子公司川宁生物至创业板上市",
    "href": "http://stock.jrj.com.cn/2020/06/24183930011503.shtml",
    "datetime": "2020-06-24 18:39:13",
    "code": "002422"
  },
  {
    "title": "[科伦药业]四川省副省长李云泽到安岳分公司调研",
    "href": "http://stock.jrj.com.cn/2020/06/23000029998157.shtml",
    "datetime": "2020-06-23 00:00:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：ACV203项目为磷酸奥司他韦胶囊的仿制药",
    "href": "http://stock.jrj.com.cn/2020/06/11094529896456.shtml",
    "datetime": "2020-06-11 09:45:56",
    "code": "002422"
  },
  {
    "title": "科伦药业：员工股权激励“双管齐下” “重金”激发人才创新活力",
    "href": "http://stock.jrj.com.cn/2020/06/04104129843035.shtml",
    "datetime": "2020-06-04 10:41:11",
    "code": "002422"
  },
  {
    "title": "科伦药业短期融资券发行 总额为6亿元",
    "href": "http://stock.jrj.com.cn/2020/05/14200529673617.shtml",
    "datetime": "2020-05-14 20:05:35",
    "code": "002422"
  },
  {
    "title": "科伦药业：盐酸达泊西汀片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/05/08192529620983.shtml",
    "datetime": "2020-05-08 19:25:00",
    "code": "002422"
  },
  {
    "title": "科伦药业第一季度盈利2188.92万同比下滑93.48% 研发费用同比增加",
    "href": "http://stock.jrj.com.cn/2020/05/01165329440496.shtml",
    "datetime": "2020-05-01 16:53:07",
    "code": "002422"
  },
  {
    "title": "科伦药业：三发驱动 创新增长 高质量发展转型持续推进",
    "href": "http://stock.jrj.com.cn/2020/04/30153629431605.shtml",
    "datetime": "2020-04-30 15:36:10",
    "code": "002422"
  },
  {
    "title": "科伦药业2019年净利9.38亿减少22.68% 毛利润增长",
    "href": "http://stock.jrj.com.cn/2020/04/28220029408213.shtml",
    "datetime": "2020-04-28 22:00:35",
    "code": "002422"
  },
  {
    "title": "科伦药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/28100029401802.shtml",
    "datetime": "2020-04-28 10:00:02",
    "code": "002422"
  },
  {
    "title": "科伦药业大宗交易成交588.93万元",
    "href": "http://stock.jrj.com.cn/hotstock/2020/04/23210629360684.shtml",
    "datetime": "2020-04-23 21:06:00",
    "code": "002422"
  },
  {
    "title": "科伦药业2020年第一季度净利0万元-3356.88万元 同比下降100%-90%",
    "href": "http://stock.jrj.com.cn/2020/04/15114129294560.shtml",
    "datetime": "2020-04-15 11:41:02",
    "code": "002422"
  },
  {
    "title": "科伦药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15080029292357.shtml",
    "datetime": "2020-04-15 08:00:38",
    "code": "002422"
  },
  {
    "title": "科伦药业：创新抗体偶联药物注射用SKB264获临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/04/09082329242336.shtml",
    "datetime": "2020-04-09 08:23:13",
    "code": "002422"
  },
  {
    "title": "科伦药业股东刘思川增持397万股 耗资约8248万元",
    "href": "http://stock.jrj.com.cn/2020/03/20192429071359.shtml",
    "datetime": "2020-03-20 19:24:55",
    "code": "002422"
  },
  {
    "title": "科伦药业：董事、总经理增持公司24.4万股",
    "href": "http://stock.jrj.com.cn/2020/03/20155329069603.shtml",
    "datetime": "2020-03-20 15:53:49",
    "code": "002422"
  },
  {
    "title": "科伦药业董事王晶翼增持10万股 耗资约204万元",
    "href": "http://stock.jrj.com.cn/2020/03/19185829062697.shtml",
    "datetime": "2020-03-19 18:58:45",
    "code": "002422"
  },
  {
    "title": "科伦药业：公司董事、首席科学家王晶翼增持逾10万股",
    "href": "http://stock.jrj.com.cn/2020/03/19163829061506.shtml",
    "datetime": "2020-03-19 16:38:00",
    "code": "002422"
  },
  {
    "title": "科伦药业副总经理潘慧辞职 2018年薪酬为90万元",
    "href": "http://stock.jrj.com.cn/2020/02/28123428913403.shtml",
    "datetime": "2020-02-28 12:34:13",
    "code": "002422"
  },
  {
    "title": "科伦药业2019年盈利9.35亿元下滑23% 研发费用大幅增加",
    "href": "http://stock.jrj.com.cn/2020/02/28101228911972.shtml",
    "datetime": "2020-02-28 10:12:15",
    "code": "002422"
  },
  {
    "title": "科伦药业：2019年实现净利润9.35亿元 同比下降22.89%",
    "href": "http://stock.jrj.com.cn/2020/02/27203928908760.shtml",
    "datetime": "2020-02-27 20:39:00",
    "code": "002422"
  },
  {
    "title": "科伦药业披露4个抗新型病毒药物研发情况",
    "href": "http://stock.jrj.com.cn/2020/02/17114728837920.shtml",
    "datetime": "2020-02-17 11:47:20",
    "code": "002422"
  },
  {
    "title": "科伦药业：洛匹那韦/利托那韦片预计3月初可批量生产",
    "href": "http://stock.jrj.com.cn/2020/02/17084628836610.shtml",
    "datetime": "2020-02-17 08:46:31",
    "code": "002422"
  },
  {
    "title": "科伦药业公布4个抗新型病毒药物研发情况：洛匹那韦3月初可批量生产",
    "href": "http://stock.jrj.com.cn/2020/02/17081028836429.shtml",
    "datetime": "2020-02-17 08:10:53",
    "code": "002422"
  },
  {
    "title": "科伦药业：公司股东所持部分股份遭被动减持",
    "href": "http://stock.jrj.com.cn/2020/02/14204028831359.shtml",
    "datetime": "2020-02-14 20:40:00",
    "code": "002422"
  },
  {
    "title": "科伦药业为子公司5000万元流动资金贷款提供担保",
    "href": "http://stock.jrj.com.cn/2020/02/10200928804665.shtml",
    "datetime": "2020-02-10 20:09:19",
    "code": "002422"
  },
  {
    "title": "科伦药业获得化学药品“盐酸替罗非班氯化钠注射液”的《药品注册批件》",
    "href": "http://stock.jrj.com.cn/2020/02/10092228800926.shtml",
    "datetime": "2020-02-10 09:22:47",
    "code": "002422"
  },
  {
    "title": "科伦药业获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/02/10081028800613.shtml",
    "datetime": "2020-02-10 08:10:47",
    "code": "002422"
  },
  {
    "title": "科伦药业完成上市公司首单“抗疫债”发行",
    "href": "http://stock.jrj.com.cn/2020/02/07001428786528.shtml",
    "datetime": "2020-02-07 00:14:38",
    "code": "002422"
  },
  {
    "title": "科伦药业正快速推进抗新冠病毒药物研究",
    "href": "http://stock.jrj.com.cn/2020/01/31130428744903.shtml",
    "datetime": "2020-01-31 13:04:39",
    "code": "002422"
  },
  {
    "title": "科伦药业获得化学药品“唑来膦酸注射液”的《药品注册批件》",
    "href": "http://stock.jrj.com.cn/2020/01/17233228695481.shtml",
    "datetime": "2020-01-17 23:32:28",
    "code": "002422"
  },
  {
    "title": "科伦药业：唑来膦酸注射液获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/17160628693052.shtml",
    "datetime": "2020-01-17 16:06:00",
    "code": "002422"
  },
  {
    "title": "科伦药业奥硝唑片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/01/14181428676125.shtml",
    "datetime": "2020-01-14 18:14:30",
    "code": "002422"
  },
  {
    "title": "科伦药业：奥硝唑片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/01/14160128675461.shtml",
    "datetime": "2020-01-14 16:01:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：羟乙基淀粉130/0.4电解质注射液获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/01174628613809.shtml",
    "datetime": "2020-01-01 17:46:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：配股申请获证监会核准",
    "href": "http://stock.jrj.com.cn/2019/12/20212828564585.shtml",
    "datetime": "2019-12-20 21:28:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：吉非替尼片获批 创新增长战略持续推进",
    "href": "http://stock.jrj.com.cn/2019/12/13132828529467.shtml",
    "datetime": "2019-12-13 13:28:56",
    "code": "002422"
  },
  {
    "title": "科伦药业吉非替尼片获批 将分羹逾30亿中国市场",
    "href": "http://stock.jrj.com.cn/2019/12/13034428527132.shtml",
    "datetime": "2019-12-13 03:44:41",
    "code": "002422"
  },
  {
    "title": "科伦药业吉非替尼片获注册批件 将分润逾30亿元中国市场",
    "href": "http://stock.jrj.com.cn/2019/12/12211928526473.shtml",
    "datetime": "2019-12-12 21:19:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：吉非替尼片获药品注册批件 主要用于治疗肺癌患者",
    "href": "http://stock.jrj.com.cn/2019/12/12160328524945.shtml",
    "datetime": "2019-12-12 16:03:36",
    "code": "002422"
  },
  {
    "title": "科伦药业：吉非替尼片获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/12155428524923.shtml",
    "datetime": "2019-12-12 15:54:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：吉非替尼片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/12154428524884.shtml",
    "datetime": "2019-12-12 15:44:09",
    "code": "002422"
  },
  {
    "title": "科伦药业将花不超2亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2019/12/09210928510373.shtml",
    "datetime": "2019-12-09 21:09:27",
    "code": "002422"
  },
  {
    "title": "科伦药业：拟斥资1亿-2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/12/06192428501153.shtml",
    "datetime": "2019-12-06 19:24:07",
    "code": "002422"
  },
  {
    "title": "科伦药业2亿元回购完成未能挽救股价 控股股东再推2亿元回购计划",
    "href": "http://stock.jrj.com.cn/2019/12/05092928492312.shtml",
    "datetime": "2019-12-05 09:29:38",
    "code": "002422"
  },
  {
    "title": "科伦药业：控股股东提议回购不超过2亿元公司股票",
    "href": "http://stock.jrj.com.cn/2019/12/04204028490530.shtml",
    "datetime": "2019-12-04 20:40:20",
    "code": "002422"
  },
  {
    "title": "科伦药业完成回购 控股股东提议1亿至2亿元新回购计划",
    "href": "http://stock.jrj.com.cn/2019/12/04203728490538.shtml",
    "datetime": "2019-12-04 20:37:34",
    "code": "002422"
  },
  {
    "title": "科伦药业：完成股份回购 控股股东提议1亿元至2亿元新回购计划",
    "href": "http://stock.jrj.com.cn/2019/12/04201828490498.shtml",
    "datetime": "2019-12-04 20:18:00",
    "code": "002422"
  },
  {
    "title": "科伦药业：控股股东提议1亿至2亿元新回购计划",
    "href": "http://stock.jrj.com.cn/2019/12/04201628490454.shtml",
    "datetime": "2019-12-04 20:16:32",
    "code": "002422"
  },
  {
    "title": "科伦药业：阿莫西林颗粒通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/11/26154528452998.shtml",
    "datetime": "2019-11-26 15:45:25",
    "code": "002422"
  },
  {
    "title": "科伦药业：“三发驱动”引领发展 股份回购彰显信心",
    "href": "http://stock.jrj.com.cn/2019/11/21114528431403.shtml",
    "datetime": "2019-11-21 11:45:47",
    "code": "002422"
  },
  {
    "title": "科伦药业：配股申请获证监会审核通过",
    "href": "http://stock.jrj.com.cn/2019/11/17192028409148.shtml",
    "datetime": "2019-11-17 19:20:00",
    "code": "002422"
  },
  {
    "title": "科伦药业与中国银行伊犁分行签订《保证合同》 为子公司提供连带责任保证担保",
    "href": "http://stock.jrj.com.cn/2019/11/11221728382125.shtml",
    "datetime": "2019-11-11 22:17:49",
    "code": "002422"
  },
  {
    "title": "科伦药业：阿哌沙班片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/11/11173828380753.shtml",
    "datetime": "2019-11-11 17:38:48",
    "code": "002422"
  },
  {
    "title": "科伦药业：肝素钠封管注射液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/11/11173628380726.shtml",
    "datetime": "2019-11-11 17:36:04",
    "code": "002422"
  },
  {
    "title": "科伦药业第三季度盈利1.86亿 同比下滑25.41%",
    "href": "http://stock.jrj.com.cn/2019/10/31140728332998.shtml",
    "datetime": "2019-10-31 14:07:56",
    "code": "002422"
  },
  {
    "title": "科伦药业：前三季度净利9.14亿元 同比下降11%",
    "href": "http://stock.jrj.com.cn/2019/10/30222328328484.shtml",
    "datetime": "2019-10-30 22:23:40",
    "code": "002422"
  }
]